Ima Wealth, Inc. Bristol Myers Squibb CO Transaction History

Ima Wealth, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$40.25 - $52.99 $212,600 - $279,893	5,282 New	5,282 $219,000
Q2 2023 Aug 15, 2023	BUY	$63.71 - $70.74 $12,869 - $14,289	202 Added 3.62%	5,782 $369,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $13,273 - $15,055	-202 Reduced 3.49%	5,580 $386,000
Q2 2022 Aug 18, 2022	BUY	$72.62 - $79.98 $36,310 - $39,990	500 Added 9.47%	5,782 $445,000
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $981 - $1,112	-17 Reduced 0.32%	5,282 $328,000
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $976 - $1,081	17 Added 0.32%	5,299 $319,000
Q4 2019 Feb 24, 2020	BUY	$49.21 - $64.19 $17,223 - $22,466	350 Added 7.1%	5,282 $339,000
Q2 2019 Jul 19, 2019	BUY	$44.62 - $49.34 $18,026 - $19,933	404 Added 8.92%	4,932 $224,000
Q4 2017 Feb 05, 2018	BUY	$59.94 - $65.35 $271,408 - $295,904	4,528	4,528 $277,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ima Wealth, Inc., based on Form 13F filings with the SEC.

Stay updated on Ima Wealth, Inc. with notifications on news.